Literature DB >> 28776358

Comorbidities and related factors in rheumatoid arthritis patients of south India- Karnataka Rheumatoid Arthritis Comorbidity (KRAC) study.

S Chandrashekara1, V Shobha, B G Dharmanand, R Jois, S Kumar, K M Mahendranath, V Haridas, S Prasad, Y Singh, M A Daware, A Swamy, R Subramanian, S A Somashekar, A M Shanthappa, K R Anupama.   

Abstract

The aim was to study the prevalence of comorbidities in rheumatoid arthritis (RA) patients in everyday clinical practice and their association with disease-specific and demographic factors. The multi-center study recruited 3,247 (at 14 centers, and 265) were excluded due to incomplete data. The number of subjects considered for the analysis was 2982. The mean (±standard deviation) age was 48.98±12.64 years and the male-to-female ratio was 1:5. The data was collected based on a pre-structured pro forma by trained clinical research associates through interview and verification of charts and reports available in the patient records. The following comorbidities were studied: cardiovascular disease, hypertension, diabetes mellitus, hypercholesterolemia, thyroid disease, psychiatric diseases like depression, and pulmonary disease. Hypertension (20.7%), diabetes mellitus (14.4%) and thyroid disease (18.3%) were the most prevalent comorbidities. Hypercholesterolemia (5.3%), pulmonary diseases (2.1%), cardiovascular diseases (0.2%) and depression (0.03%) were prevalent in ≤5% of the study population. The overall presence of comorbidity increased with age and reduced with the duration of illness prior (DOIP). The age, gender, and DOIP differed significantly between groups with and without hypercholesterolemia. Females had a statistically increased prevalence of thyroid disease. The prevalence of comorbidities in RA patients from south India is around 40% and the incidence of comorbidity increased with age. As per the literature evidence, the prevalence in the current study subjects was higher when compared to prevalence of similar diseases occurring in the general south Indian population.

Entities:  

Mesh:

Year:  2017        PMID: 28776358     DOI: 10.4081/reumatismo.2017.898

Source DB:  PubMed          Journal:  Reumatismo        ISSN: 0048-7449


  4 in total

1.  Possible use of miRNAs-146a and -499 expression and their polymorphisms as diagnostic markers for rheumatoid arthritis.

Authors:  Ghada Ayeldeen; Yasser Nassar; Hanan Ahmed; Olfat Shaker; Tamer Gheita
Journal:  Mol Cell Biochem       Date:  2018-04-26       Impact factor: 3.396

2.  The comparison of cardiovascular disease risk prediction scores and evaluation of subclinical atherosclerosis in rheumatoid arthritis: a cross-sectional study.

Authors:  Hafis Muhammed; Durga Prasanna Misra; Neeraj Jain; Sujata Ganguly; Sarit Sekhar Pattanaik; Mohit K Rai; Anamika Kumari Anuja; Namita Mohindra; Sudeep Kumar; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2022-08-25       Impact factor: 3.650

3.  A randomised controlled trial of a Mediterranean Dietary Intervention for Adults with Rheumatoid Arthritis (MEDRA): Study protocol.

Authors:  Tala Raad; Elena George; Anne Griffin; Louise Larkin; Alexander Fraser; Norelee Kennedy; Audrey Tierney
Journal:  Contemp Clin Trials Commun       Date:  2022-05-03

4.  Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study.

Authors:  Maria Antonietta Barbieri; Giuseppe Cicala; Paola Maria Cutroneo; Elisabetta Gerratana; Caterina Palleria; Caterina De Sarro; Ada Vero; Luigi Iannone; Antonia Manti; Emilio Russo; Giovambattista De Sarro; Fabiola Atzeni; Edoardo Spina
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.